Association between a Marker on Chromosome 9 and Acute Coronary Syndrome Confirmatory Study on Czech Population

Jaroslav A. Hubáček(Institute of Clinical and Experimental Medicine), Jan Piťha(Centre of Civil Engineering (Czechia)), R. Poledne(Institute of Clinical and Experimental Medicine), M Gebauerová(Institute of Clinical and Experimental Medicine), Jana Matoušková(General University Hospital in Prague), Martin Pěnička, Hana Skalická(University of Iowa), Hana Hrabáková(University Hospital Kralovske Vinohrady), Josef Veselka(Baim Institute for Clinical Research), V Lánská(Institute of Clinical and Experimental Medicine), V. Staněk(Institute of Clinical and Experimental Medicine), V Adámková(University of South Bohemia in České Budějovice), Michael Aschermann, A. Krüger(Na Homolce Hospital), Petr Hájek(University Hospital in Motol)
Folia Biologica
January 1, 2012
10.14712/fb2012058050203
Cited by 12

Related Papers

HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
|The Lancet|2014|709
Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data
|BMJ|2014|677
Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest
|JAMA|2022|674
Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study
|European Heart Journal - Cardiovascular Imaging|2017|348
Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study
|European Heart Journal - Cardiovascular Imaging|2018|336